Virulence enhancement of a filamentous strain of Candida albicans after growth on media containing cysteine.
作者信息
WINSTEN S, MURRAY T J
出版信息
J Bacteriol. 1956 Jun;71(6):738. doi: 10.1128/jb.71.6.738-738.1956.
Abstract
摘要
相似文献
1
Virulence enhancement of a filamentous strain of Candida albicans after growth on media containing cysteine.
J Bacteriol. 1956 Jun;71(6):738. doi: 10.1128/jb.71.6.738-738.1956.
2
[Serum media containing tellurite for the differentiation of Candida albicans].
Zentralbl Bakteriol Orig. 1956 Mar;165(4):264-74.
3
Comparative studies of special media for identifying Candida albicans from other candidas and molds.
J Invest Dermatol. 1957 Oct;29(4):263-7. doi: 10.1038/jid.1957.99.
4
[New medium for formation of pseudomycelium in Candida albicans].
Z Hyg Infektionskr. 1955;141(5):488-94.
5
A re-evaluation of the effect of cysteine or Candida albicans.
Sabouraudia. 1975 Mar;13 Pt 1:74-82.
6
Pagano-Levin medium for the isolation and identification of Candida albicans.
J Invest Dermatol. 1960 Mar;34:229-30.
7
The enhancement of the virulence of Candida albicans in mice.
J Infect Dis. 1952 Mar-Apr;90(2):177-82. doi: 10.1093/infdis/90.2.177.
8
Rapid identification of Candida albicans by filamentation on serum and serum substitutes.
AMA J Dis Child. 1960 Feb;99:212-5. doi: 10.1001/archpedi.1960.02070030214011.
9
An apparent growth stimulant for Candida albicans released from tetracycline-treated bacterial flora.
J Hyg (Lond). 1960 Mar;58(1):95-7. doi: 10.1017/s0022172400038146.
10
Virulence enhancement of Candida albicans by antibiotics and cortisone.
Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):778-81. doi: 10.3181/00379727-83-20488.
引用本文的文献
1
A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
PLoS One. 2014 May 27;9(5):e97864. doi: 10.1371/journal.pone.0097864. eCollection 2014.
2
Factors supporting cysteine tolerance and sulfite production in Candida albicans.
Eukaryot Cell. 2013 Apr;12(4):604-13. doi: 10.1128/EC.00336-12. Epub 2013 Feb 15.
3
[A critical review of medical mycology in the United States 1946-1956].
Mycopathol Mycol Appl. 1957 Dec 20;8(4):271-326. doi: 10.1007/BF02052297.
4
Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells.
Infect Immun. 1980 May;28(2):464-8. doi: 10.1128/iai.28.2.464-468.1980.
5
Changes in cyclic nucleotide levels and dimorphic transition in Candida albicans.
J Bacteriol. 1980 Jun;142(3):1010-4. doi: 10.1128/jb.142.3.1010-1014.1980.
6
Simple rapid identification of Candida albicans with emphasis on the differentiation between Candida albicans and Candida stellatoidea.
Mycopathol Mycol Appl. 1968 Jul 12;35(2):105-12. doi: 10.1007/BF02049573.
7
Monitored environment system to control cell growth, morphology, and metabolic rate in fungi by oxidation-reduction potentials.
Appl Microbiol. 1968 Jan;16(1):114-21. doi: 10.1128/am.16.1.114-121.1968.
8
Pathogenicity of the Y form as compared to M form in experimentally induced Candida albicans infections.
Mycopathol Mycol Appl. 1973 Sep 28;51(1):19-28. doi: 10.1007/BF02141282.
9
Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
Infect Immun. 1985 Nov;50(2):541-4. doi: 10.1128/iai.50.2.541-544.1985.
10
Autoregulation of germ tube formation by Candida albicans.
Infect Immun. 1979 Jun;24(3):661-6. doi: 10.1128/iai.24.3.661-666.1979.
Zotero 插件